The Life Sciences Innovative Manufacturing Fund (LSIMF) is part of the Global Britain Investment Fund, of which £354 million will support life sciences manufacturing.

The LSIMF will provide £60 million in capital grants for investment in the manufacture of:

  • human medicines (drug substance and drug product)
  • medical diagnostics
  • MedTech products

The Department for Business, Energy & Industrial Strategy (BEIS) encourage applications from companies ready to deploy their emerging technologies at scale in commercial manufacturing.

See: Life Sciences Innovative Manufacturing Fund (LSIMF) – GOV.UK (www.gov.uk)